Format

Send to

Choose Destination
N Engl J Med. 2008 Jun 19;358(25):2698-703. doi: 10.1056/NEJMoa0800251.

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.

Author information

1
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Abstract

We developed an in vitro method for isolating and expanding autologous CD4+ T-cell clones with specificity for the melanoma-associated antigen NY-ESO-1. We infused these cells into a patient with refractory metastatic melanoma who had not undergone any previous conditioning or cytokine treatment. We show that the transferred CD4+ T cells mediated a durable clinical remission and led to endogenous responses against melanoma antigens other than NY-ESO-1.

PMID:
18565862
PMCID:
PMC3277288
DOI:
10.1056/NEJMoa0800251
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center